Diagnosis and Treatment of Hepatobiliary and Pancreatic Neoplasms: State of the Art in 2014

Transcription

1 Diagnosis and Treatment of Hepatobiliary and Pancreatic Neoplasms: State of the Art in 2014 Saturday March 29, :00 am-5:00 pm Hilton Pasadena 168 S. Los Robles Avenue Pasadena, California Presented by: Department of Surgery & Department of Medicine USC Office of Continuing Medical Education

2 PROGRAM 7:00 AM Registration and Breakfast Liver Cancer: State of the Art 2014: Moderators: Tse-Ling Fong, M.D., Sophoclis Alexopoulos, M.D. 8:00 AM Is Liver Cancer Preventable? 8:30 AM Hepatocellular Cancer 2014: Case for Surgical Resection vs. Case for Transplant Robert Selby, M.D. & Kiran Dhanireddy, M.D. 9:00 AM Treatment of Advanced Hepatocellular Carcinoma: Going Beyond Sorafenib Anthony El-Khoueiry, M.D. 9:30 AM - quency Ablation, Endoscopic Alcohol Injection, Surgical Radiofrequency Ablation, Moderator: Tse-Ling Fong, M.D. Panel: Sue Hanks, M.D., Sujit Kulkarni, M.D., Anthony El-Khoueiry, M.D., John Donovan, M.D. and Linda Sher, M.D. 10:30 AM Break Pancreatic Cancer State of the Art 2014: Moderators: Jacques Van Dam, M.D., Ph.D. and Afsaneh Barzi, M.D., Ph.D. 10:45 AM James Buxbaum, M.D. 11:15 AM Pancreatic Neoplasia: Molecular Genetics and Genetic Screening Guidelines in 2014 Kevin McDonnell, M.D., Ph.D. 11:35 AM Chemoradiation Syma Iqbal, M.D. and SuiSui Song, M.D. 12:05 PM Panel Discussion: IPMN-Who to Treat, How to Treat and When to Treat Moderator: Dilip Parekh, M.D. Panel: Lea Matsuoka, M.D., Jacques Van Dam, M.D., Ph.D., Parakrama Chandrasoma, M.D., Vinay Duddalwar, M.D. 1:15 PM Lunch and Anthony El-Khoueiry, M.D. 2:15 PM Novel Interventional Radiological Procedures for Liver and Pancreatic Diseases Sue Hanks, M.D. 2:45 PM Minimally Invasive Surgery for Hepatobiliary and Pancreatic Cancer: New Emerging Standards of Care Dilip Parekh, M.D. 3:15 PM Break 3:30 PM New Treatments for Borderline Resectable and Locally Advanced Pancreatic Cancer: Yuri Genyk, M.D. 4:00 PM Carcinomas: Heinz-Josef Lenz, M.D., F.A.C.P. 4:30 PM Pancreatic Diseases: Ara Sahakian, M.D. 5:00 PM Adjournment

3 FACULTY COURSE DIRECTORS Dilip Parekh, M.D. Professor of Surgery Anthony El-Khoueiry, M.D. Division of Hepatology Jacques Van Dam, M.D., Ph.D. Professor of Medicine Division of Gastroenterology KECK SCHOOL OF MEDICINE OF USC Sophoclis Alexopoulos, M.D., F.A.C.S. Afsaneh Barzi, M.D., Ph.D. James Buxbaum, M.D. Division of Gastroenterology Parakrama Chandrasoma, M.D. Professor of Pathology Department of Pathology Kiran Dhanireddy, M.D. John Donovan, M.D. Division of Hepatology Vinay Duddalwar, M.D., F.R.C.R. Associate Professor of Clinical Radiology Division of Abdominal Imaging Tse-Ling Fong, M.D. Division of Hepatology Yuri Genyk, M.D. Associate Professor of Surgery Sue Hanks, M.D. Associate Professor of Clinical Radiology Department of Radiology Syma Iqbal, M.D. Sujit Kulkarni, M.D., M.Tech. Division of Hepatobiliary Surgery Heinz-Josef Lenz, M.D., F.A.C.P. Professor of Medicine Lea Matsuoka, M.D. Kevin McDonnell, M.D., Ph.D. Clinical Instructor in Internal Medicine Ara Sahakian, M.D. Division of Gastroenterology Robert Selby, M.D. Professor of Surgery Linda Sher, M.D. Professor of Surgery SuiSui Song, M.D. Assistant Clinical Professor of Radiation Oncology Department of Radiation Oncology

4 COURSE DESCRIPTION - ing integrated care plans for personalized cancer therapy of liver, bile duct and pancreatic cancers. and spawn new therapies and development of new surgical procedures provide opportunities and challenges for personalized cancer therapy of liver, bile duct and pancreatic cancers. EDUCATIONAL OBJECTIVES By the end of the course, participants will be able to: Critically evaluate new endoscopic techniques and advances in EUS in the management of liver, bile duct and pancreatic neoplasms. treatments and surgery for side branch and main duct IPMN. Assess the importance and utility of genetic screening in the management for pancreatic neoplasms. Compare and contrast the roles of regional therapies, transplantation and surgical resection in the treatment of hepatoma. Assess the potential impact of new treatments for chronic hepatitis in the prevention of hepatocellular carcinoma. and pancreatic neoplasms. Assess the role of minimally invasive surgery for liver, bile duct and pancreatic neoplasms. Apply best practice strategies for the use of new chemotherapy agents in the management of liver, bile duct and pancreatic neoplasms. Evaluate the advances in the medical and surgical treatment of locally advanced and borderline resectable pancreatic cancer. TARGET AUDIENCE medical oncologists, gastroenterologists and all allied health professionals who seek to enhance their understanding of liver, bile duct and pancreatic neoplasms and treatment options to optimize management of their patients. Credit Designation a maximum of 8.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Accreditation Statement - tion Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

5 REGISTRATION Tuition: Cancellation Fee: $100 MD, DO $75 Nurses, Allied Health Professionals if registered and paid by noon PDT on 3/5/14. Additional $25 for onsite payment. Tuition is non-refundable, unless program is cancelled by USC. only by March 27, No cancellations after March 27, Location: Hilton Pasadena: 168 S. Los Robles Avenue, Pasadena, CA Telephone: Parking: Hilton structure open to the public for $10. Entrance is on Cordova Street. Cancellation: Courses subject to cancellation. USC will not refund travel costs for cancelled courses. Register: Mail: 1540 Alcazar Street, CHP 223, Los Angeles, CA Online: scroll down to Diagnosis and Treatment of Hepatobiliary and Pancreatic Neoplasms State of the Art in 2014 Phone: I Fax: Onsite: Foyer of the San Gabriel Room. Special Needs: Advance notice of any special physical or dietary needs by March 1, 2014 will help us serve you better. PLEASE PRINT: NAME DEGREE LICENSE# (MD/RN) TELEPHONE FAX ADDRESS CITY STATE ZIP CODE SPECIALTY ADDRESS* INSTITUTIONAL AFFILIATION * Registration confirmation and event reminder will be ed. METHOD OF PAYMENT: CHECK (Payable to USC) Credit Card (Visa or Mastercard only) Visa/Mastercard # Authorized Signature Amount $

6 1540 Alcazar Street, CHP 223 Los Angeles, CA Diagnosis and Treatment of Hepatobiliary and Pancreatic Neoplasms: State of the Art in 2014: March 29, 2014 Hilton Pasadena 168 S. Los Robles Avenue Pasadena, CA Non-Profit U.S. Postage PAID University of Southern California